Genovesi Simonetta, Valsecchi Maria G, Rossi Emanuela, Pogliani Daniela, Acquistapace Irene, De Cristofaro Vincenzo, Stella Andrea, Vincenti Antonio
Department of Clinical Medicine and Prevention, University of Milano-Bicocca, Nephrology Unit, San Gerardo Hospital, Monza, Italy.
Nephrol Dial Transplant. 2009 Aug;24(8):2529-36. doi: 10.1093/ndt/gfp104. Epub 2009 Mar 16.
In haemodialysis patients, deaths due to cardiovascular causes constitute a large proportion of total mortality and sudden cardiac deaths account for approximately 22% of all deaths. The aim of this study was to evaluate the incidence of sudden cardiac death and associated risk factors in a cohort of haemodialysis patients.
The 3-year cumulative incidence of death in a cohort of 476 patients on chronic haemodialysis treatment was 34.3% (SE 2.3). Sudden death had a 6.9% (SE 1.2) cumulative incidence, with 32 events representing 19.2% of all deaths, while cardiovascular not sudden death and noncardiovascular death accounted for a 3-year cumulative incidence of 7.3% (SE 1.2) and 20.1% (SE 1.9), respectively. According to Cox multivariate analysis, significant risk factors for sudden death were the presence of atrial fibrillation, diabetes mellitus, predialytic hyperkalaemia, haemodialysis mode and C-reactive protein level, which were associated with a 2.9 (CI(95%) 1.3-6.4), 3.0 (CI(95%) 1.3-7.2), 2.7 (CI(95%) 1.3-5.8), 4.5 (CI(95%) 1.3-15.5) and 3.3 (CI(95%) 1.2-8.8)-fold increase in the risk of sudden death, respectively. Sudden death was significantly more frequent during the first 24 h of the first short interdialytic interval and during the last 24 h of the long interval, i.e. immediately before and immediately after the first weekly haemodialysis session (P = 0.02).
Our data show that the incidence of sudden death in haemodialysis patients is high and that atrial fibrillation, diabetes, hyperkalaemia, haemodialysis mode and C-reactive protein play an important role in developing fatal arrhythmia. Further studies will be necessary to define which interventions could be helpful in reducing this cause of mortality.
在血液透析患者中,心血管原因导致的死亡占总死亡率的很大比例,心脏性猝死约占所有死亡的22%。本研究的目的是评估一组血液透析患者中心脏性猝死的发生率及相关危险因素。
476例接受慢性血液透析治疗患者队列的3年累积死亡率为34.3%(标准误2.3)。心脏性猝死的累积发生率为6.9%(标准误1.2),32例事件占所有死亡的19.2%,而心血管非猝死和非心血管死亡的3年累积发生率分别为7.3%(标准误1.2)和20.1%(标准误1.9)。根据Cox多因素分析,心脏性猝死的显著危险因素包括房颤、糖尿病、透析前高钾血症、血液透析模式和C反应蛋白水平,它们分别使心脏性猝死风险增加2.9倍(95%置信区间1.3 - 6.4)、3.0倍(95%置信区间1.3 - 7.2)、2.7倍(95%置信区间1.3 - 5.8)、4.5倍(95%置信区间1.3 - 15.5)和3.3倍(95%置信区间1.2 - 8.8)。心脏性猝死在首次短透析间期的前24小时以及长透析间期的最后24小时,即首次每周血液透析治疗前和后的紧邻时段显著更频繁(P = 0.02)。
我们的数据表明,血液透析患者中心脏性猝死的发生率很高,房颤、糖尿病、高钾血症、血液透析模式和C反应蛋白在致命性心律失常的发生中起重要作用。需要进一步研究来确定哪些干预措施有助于降低这种死亡原因。